The CCL2 (MIM + 158105, C-C Motif Chemokine Ligand 2) −2518A>G promoter polymorphism has been associated with an increased risk for spina bifida in pregnant women who were homozygous for this variant [29]. Here, CCL2 is linked to spina bifida.